JWBK208-05 December 8, 2007 21:25 Char Count= 0
Paediatric and Placental 66
r
d/dg carcinoma with trophoblastic differentiation: CA produces little hCG for its bulk, has a vascular
stroma and is resistant to chemoRx. ChC contains paternal polymorphisms. Immuno unhelpful as ChC
is +ve for CK, EMA and some CEA.
r
d/dg invasive mole: moles have villi with stromal cores
r
d/dg pleomorphic trophoblast without villi in curettage specimens (see sections on CM and ‘Invasive
Hydatidiform Mole’ above) – do not diagnose ChC here without corroborating evidence
Placental Site Trophoblastic Tumour (PSTT)
r
Def
n
: a tumour of intermediate trophoblast (admixed mononuclear and multinucleate cells)
r
Clin.: amenorrhoea / irregular bleeding months (>4) or years after some gestation
r
Less metastatic but chemoresistant .
.
. Rx is surgery, not chemoRx
r
Eosinophilic pleomorphic cells (±cytoplasmic vacuoles / hyaline inclusions) infiltrating myometrium /
decidua (occasional scattered foci of syncytiotrophoblast may be present)
r
Hyaline and fibrin ++
r
Much necrosis (not haemorrhage) → tumour cells survive only around vessels and may show endovas-
cular growth (cling to or focally replace endothelium or are free in the lumen)
r
↑ Metastatic potential if mitoses > 5/10hpf
r
Immuno: more hPL than hCG +ve cells (i.e. the converse of ChC); +ve for inhibin-, AE1/AE3,
CAM5.2 and CD146 (= Mel-CAM)
r
d/dg exaggerated placental site reaction: mitoses, presentation > 4 months and large clusters of cells
favour PSTT while villi, decidua vera and many multinucleate cells favour exaggerated placental site
r
d/dg regressing placental site nodule: ↑↑ hyaline and central necrosis favour nodule
r
d/dg non-gestational carcinoma: PSTT presents with gynae Sx. Immuno: hPL more useful than hCG
Bibliography
Al-Adnani, M., Williams, S., Rampling, D., Ashworth, M., Malone, M. and Sebire, N.J. (2006) Histopathological reporting of paediatric cutaneous
vascular anomalies in relation to proposed multidisciplinary classification system. Journal of Clinical Pathology, 59 (12), 1278–1282.
Berenguer, B., Mulliken, J.B., Enjolras, O. et al. (2003) Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatric
and Developmental Pathology, 6 (6), 495–510.
Boyd, T., Gang, D., Lis, G., Juozokas, A. and Pfeuger, S. (2004) Appendix 2A in Placental Pathology, fascicle 3 in Atlas of Non-Tumor Pathology
1
st
series (eds F.T. Kraus, R.W. Redline, D.J. Gersell, D.M. Nelson and J.M. Dicke), AFIP, The American Registry of Pathology, Washington D.C.
Filipe, M.I. and Lake, B.D. (1990) Histochemistry in Pathology,2
nd
edn, Churchill Livingstone, Edinburgh.
Fox, H. (1997) Trophoblastic disease, in Progress in Pathology, (eds N. Kirkham and N.R. Lemoine), Churchill Livingstone, NY, vol. 3, pp. 86–101.
Fox, H. (1997) Pathology of the Placenta,2
nd
edn, W.B. Saunders Co. Ltd., London.
Fox, H. and Wells, M. (eds) (2002) Haines & Taylor Obstetrical and gynaecological pathology,5
th
edn, Churchill Livingstone, London.
Glickman, J.N. (April 2005) Pathology of inflammatory bowel disease in children. Current Diagnostic Pathology, 11 (2), 117–124.
Gruenwald, P. and Minh, H.N.(1961) Evaluation of body and organ weights in perinatal pathology II. Weight of body and placenta in surviving and
autopsied infants. American Journal of Obstetrics and Gynecology, 82 (2), 313–319.
Guillou, L., Coquet, M., Chaubert, P. and Coindre, J.M. (1998) Skeletal muscle regeneration mimicking rhabdomyosarcoma: a potential diagnostic
pitfall. Histopathology, 33 (2), 136–144.
Hargitai, B., Marton, T. and Cox, P.M. (2004) Examination of the human placenta. Journal of Clinical Pathology, 57 (8), 785–792.
Lage, J.M., Minamiguchi, S. and Richardson, M.S. (Feb 2003) Gestational trophoblastic diseases: update on new immunohistochemical findings.
Current Diagnostic Pathology, 9 (1),1–10.
Meijer-Jorna, L.B, van der Loos, C.M., de Boer, O.J., et al. (2007) Microvascular proliferation in congenital vascular malformations of skin and soft
tissue. Journal of Clinical Pathology, 60 (7), 798–803.
Moore, I.E. and Baxendine-Jones, J. (2001) Diagnosis and molecular pathology of Hirschprung’s disease, in Recent Advances in Histopathology,
(eds D. Lowe, J.C.E. Underwood), Churchill Livingstone, Edinburgh, vol. 19, pp. 51–66.
Out, H.J., Kooijman, C.D., Bruinse, H.W. and Derksen, R.H. (1991) Histopathological findings in placentae from patients with intrauterine fetal death
and anti-phospholipid antibodies. European Journal of Obstetrics, Gynecology and Reproductive Biology, 41 (3), 179–186.
Paradinas, F.J. (June 1998) The differential diagnosis of choriocarcinoma and placental site tumour. Current Diagnostic Pathology, 5 (2), 93–101.
Pinar, H., Sung, C.J., Oyer, C.E. and Singer, D.B. (1996) Reference values for singleton and twin placental weights. Pediatric Pathology and
Laboratory Medicine, 16 (6), 901–907.
Sebire, N.J., Fox, H., Backos, M. et al. (2002) Defective endovascular trophoblast invasion in primary antiphospholipid antibody syndrome-associated
early pregnancy failure. Human Reproduction, 17 (4), 1067–1071.
Sebire, N.J., Backos, M., Gaddal, S., et al. (2003) Placental pathology,antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage
patients. Obstetric Gynecology, 101, 258–263.
Sebire, N.J. and Rees, H. (2002) Diagnosis of gestational trophoblastic disease in early pregnancy. Current Diagnostic Pathology, 8 (6), 430–440.
Skordilias, K. and Howatson, A.G. (2003) The diagnostic challengeof paediatric small round cell tumours,in Progress in Pathology, (eds N.Kirkham,
N.A. Shepherd), Greenwich Medical Media Ltd, London, vol. 6, pp. 1–27.